| 摘要 |
The present invention relates to a pharmaceutical composition comprising HGF (Hepatocyte growth factor) and to the use of HGF for the manufacture of such pharmaceutical composition comprising HGF in a dose sufficient for the immunisation in a mammal suffering from cancer. The invention further relates to a method for the treatment cancer using the 5 pharmaceutical composition comprising HGF in a dose sufficient to cause an active immunisation in a mammal. |
